Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The location of locoregional recurrence in pathologic T3N0, non-irradiated lower rectal cancer.

Kim MS, Keum KC, Rhee WJ, Kim H, Kim M, Choi S, Nam KC, Koom WS.

Radiat Oncol J. 2013 Jun;31(2):97-103. doi: 10.3857/roj.2013.31.2.97.

2.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM)..

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39.

PMID:
16414206
3.

Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.

Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH.

Am J Clin Oncol. 2006 Jun;29(3):219-24.

PMID:
16755173
4.

T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.

Sanfilippo NJ, Crane CH, Skibber J, Feig B, Abbruzzese JL, Curley S, Vauthey JN, Ellis LM, Hoff P, Wolff RA, Brown TD, Cleary K, Wong A, Phan T, Janjan NA.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):176-83.

PMID:
11516868
5.

Rectal cancer: local recurrence after surgery without radiotherapy.

Bonadeo FA, Vaccaro CA, Benati ML, Quintana GM, Garione XE, Telenta MT.

Dis Colon Rectum. 2001 Mar;44(3):374-9.

PMID:
11289283
6.

Local excision and postoperative radiotherapy for distal rectal cancer.

Benson R, Wong CS, Cummings BJ, Brierley J, Catton P, Ringash J, Abdolell M.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1309-16.

PMID:
11483343
7.

Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer.

Yu TK, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Das P.

Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1175-80. doi: 10.1016/j.ijrobp.2007.11.018.

PMID:
18207667
8.

Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.

Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):786-96.

PMID:
14967435
9.

Short versus conventional preoperative radiotherapy of rectal cancer: indications.

Klenova A, Georgiev R, Kurtev P, Kurteva G.

J BUON. 2007 Apr-Jun;12(2):227-32.

PMID:
17600877
10.

Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.

Willner J, Kiricuta IC, Kölbl O.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):853-63.

PMID:
9128962
11.

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.

Azria D, Bibeau F, Barbier N, Zouhair A, Lemanski C, Rouanet P, Ychou M, Senesse P, Ozsahin M, Pèlegrin A, Dubois JB, Thèzenas S.

BMC Cancer. 2005 Jun 20;5:62.

12.

Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.

Ngan SY, Burmeister B, Fisher RJ, Solomon M, Goldstein D, Joseph D, Ackland SP, Schache D, McClure B, McLachlan SA, McKendrick J, Leong T, Hartopeanu C, Zalcberg J, Mackay J.

J Clin Oncol. 2012 Nov 1;30(31):3827-33. doi: 10.1200/JCO.2012.42.9597. Erratum in: J Clin Oncol. 2013 Jan 20;31(3):399.

PMID:
23008301
13.

Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer.

Petrovich Z, Lieskovsky G, Langholz B, Jozsef G, Streeter OE Jr, Skinner DG.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):600-9.

PMID:
12062603
14.

Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy?

Willett CG, Badizadegan K, Ancukiewicz M, Shellito PC.

Dis Colon Rectum. 1999 Feb;42(2):167-73.

PMID:
10211491
15.

Nonrandomized comparison of surgery with and without adjuvant pelvic irradiation for patients with pT3N0 adenocarcinoma of the prostate.

Petrovich Z, Lieskovsky G, Langholz B, Huberman M, Streeter O, Skinner DG.

Am J Clin Oncol. 2001 Dec;24(6):537-46.

PMID:
11801750
17.

Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer.

Edler D, Hallström M, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H.

Clin Cancer Res. 2000 Apr;6(4):1378-84.

18.

T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy.

Merchant NB, Guillem JG, Paty PB, Enker WE, Minsky BD, Quan SH, Wong D, Cohen AM.

J Gastrointest Surg. 1999 Nov-Dec;3(6):642-7.

PMID:
10554372
19.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Review.

PMID:
17687650
20.

Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer.

Petrovich Z, Lieskovsky G, Stein JP, Huberman M, Skinner DG.

BJU Int. 2002 Apr;89(6):604-11.

Items per page

Supplemental Content

Support Center